Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma

CMV-, EBV- and ADV-Specific T Cell Immunity: Screening and Monitoring of Potential Third-Party Donors to Improve Post-Transplantation Outcome

(2013) Cinja Sukdolak et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

(2013) Ulrike Gerdemann et al.   MOLECULAR THERAPY

T-helper-1-cell cytokines drive cancer into senescence

(2013) Heidi Braumüller et al.   NATURE

Type I IFN Induced by Adenovirus Serotypes 28 and 35 Has Multiple Effects on T Cell Immunogenicity

(2012) M. J. Johnson et al.   JOURNAL OF IMMUNOLOGY

Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10

(2012) Lazar Vujanovic et al.   OncoImmunology

Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity

(2012) LeeAnn T. Blalock et al.   OncoImmunology

Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans

(2011) Samuel O. Pine et al.   PLoS One

Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15

(2010) L. Vujanovic et al.   BLOOD

Generation and maintenance of memory CD4+ T Cells

(2009) Ester MM van Leeuwen et al.   CURRENT OPINION IN IMMUNOLOGY

Adenovirus MART-1–engineered Autologous Dendritic Cell Vaccine for Metastatic Melanoma

(2009) Lisa H. Butterfield et al.   JOURNAL OF IMMUNOTHERAPY

Replication-Defective Adenovirus Vectors with Multiple Deletions Do Not Induce Measurable Vector-Specific T Cells in Human Trials

(2009) R. A. Koup et al.   JOURNAL OF VIROLOGY

Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus

(2008) Lazar Vujanovic et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

CD56brightnatural killer (NK) cells: an important NK cell subset

(2008) Aurélie Poli et al.   IMMUNOLOGY

Clinical Grade Generation of Hexon-specific T Cells for Adoptive T-cell Transfer as a Treatment of Adenovirus Infection After Allogeneic Stem Cell Transplantation

(2008) Tobias Feuchtinger et al.   JOURNAL OF IMMUNOTHERAPY

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

(2008) Susan P Buchbinder et al.   LANCET